DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20191596

Knowledge, attitude and practices of generic names usage in prescription among the medical postgraduate residents of a tertiary care teaching hospital: an observational cross-sectional study

Rakesh R. Jadhav, Rushikesh S. Kulkarni, Arati V. Rathod

Abstract


Background: Establishment of Pradhan Mantri Bhartiya Janaushadhi Kendras through Pradhan Mantri Janaushadhi Pariyojana (PMBJP) is a breakthrough step to reduce expenses in healthcare due to costly branded names in prescription. Medical council of India also amended clause 1.5 of the Indian Medical Council Regulations, 2002 mandating the doctors to prescribe medicines by generic names in place of brand names. Moreover, medical practitioner nowadays has raised concern about education/qualification of the chemist who is being made the decision maker.

Methods: In this questionnaire based cross-sectional observational study, all students admitted to post graduation course in academic year 2018 were included and those who were not willing to give consent were excluded from study. A knowledge, attitude and practices (KAP) questionnaire containing 12 questions was assessed by using true/false type and Likert scale-based questions. Descriptive statistics used to generate frequencies, percentages and proportions.

Results: Majority of the population have answered positively about knowledge questions. Surprisingly 72.41% population don’t know about process of new drug approval. Most of them agreed to pros and cons of generic drug prescribing. 58.14% population always write generic names in their prescription. Shockingly 74.42% population write prescription based on their knowledge from promotional literature by a medical representative.

Conclusions: Findings of present study highlights usefulness of the practice of writing generic names in prescriptions. It also raises concern about professional qualification of the chemist who will be decision maker in drug delivery to consumers.


Keywords


Attitude, Generic, Janaushadhi, Knowledge, Practice, Prescription

Full Text:

PDF

References


Thakkar K, Billa G. The concept of generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs. Frontiers Pharmacol. 2013;12(4):113.

Andrade C, Rao TS. Prescription writing: generic or brand?. Ind J Psychiatry. 2017;59(2):133.

Flegel K. The adverse effects of brand-name drug prescribing. CMAJ. 2012;184(5):616.

Bureau of Pharma PSUs of India (BPPI), Government of India. Available at: http://www.janaushadhi.gov.in/aboutbppi.aspx. Accessed 10 October 2018.

Doctors to face action unless they only prescribe generic drugs. MCI India News Times of India. Available at: https://timesofindia.indiatimes.com/india/doctors-to-face-action-unless-they-only-prescribe-generic-drugs-mci/articleshow/58314973.cms. Accessed 10 Oct 2018.

Kamerow D. The pros and cons of generic drugs. BMJ. 2011;343:d4584.

Generic drugs. 73 per cent of doctors oppose push for generic drugs. Study India News Times of India. Available at: https://timesofindia.indiatimes.com/india/73-per-cent-of-doctors-oppose-push-for-generic-drugs-study/articleshow/58584346.cms. Accessed 10 Oct 2018.

Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, Dhroptee B, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci. 2010;32(4):440-8.

Naing C, Kai YC, Yi CH, Yee NS, Yi LM, Jun LX, et al. Knowledge of medication use and factors influencing the utilisation of public health clinics. Int Heal. 2013;5(3):217-22.

Badwaik RT, Chopade SS, Mahajan HM, Honrao R. Prescribers views on generic medicines: A study on knowledge, attitude and practice. J Cont Med A Dent. 2015;3(2):27-32.

Singal GL, Nanda A, Kotwani A. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Ind J Pharmacol. 2011;43(2):131.

Mathew P. Generic drugs: Review and experiences from South India. J Family Med Primary Care. 2015;4(3):319.

Lopes GD. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Ann Oncol. 2013;24(5):v13-6.

Thomas R, Vitry A. Consumer's perception of generic medicines in community pharmacies in Malaysia. Southern Med Rev. 2009;2(2).

Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacotherapy. 2009;43(10):1583-97.

Gupta SK, Nayak RP, Vidyarthi SK. A study on the knowledge, attitude, and practice of generic medicines among the doctors in a tertiary care teaching hospital in South India. National J Physiol Pharm Pharmacol. 2015;5(1):39.

Ritter J, Flower RJ, Rod J, Henderson G, Loke YK, MacEwan DJ, Rang HP. Rang and Dale’s Pharmacology. 9th ed. London: Elsevier; 2019:808.

Stahl SM. Stahl’s Essential Psychopharmacology Neuroscientific Basis and Third Edition. 3rd ed. Newyork: Cambridge University Press; 2008.